Synthace

The UK’s first dedicated synthetic biology company with a world leading platform of technologies for the rapid engineering and optimisation of novel biological production systems. A spin out of University College London, Synthace is already producing high-value research and development products for the pharmaceutical, agrochemical and fine chemicals industry. Synthace bioengineering is enabled by a tight integration of computational modelling and big data analysis with wet lab experimental design and validation, and novel molecular biology tools. While Synthace bioengineering is broadly applicable across multiple industry sectors, the company is focused towards applications in the production of specialty chemicals.
Type
Private
HQ
London, GB
Founded
2011
Employees
25 (est)-7%
Synthace was founded in 2011 and is headquartered in London, GB

Key People at Synthace

Tim Fell

Tim Fell

CEO
Christopher Grant Ward

Christopher Grant Ward

Co-Founder
Markus Gershater

Markus Gershater

CSO
Sean Ward

Sean Ward

Founder and CTO

Synthace Locations

London, GB

Synthace Metrics

Synthace Summary

Founding Date

2011

Total Funding

$2.87 M

Latest funding size

$1.88 M

Time since last funding

over 3 years

Investors

We estimate that Synthace's latest funding round in September 2013 was $1.88 M. In total, Synthace has raised $2.87 M

Synthace Online Presence

Synthace Company Life

You may also be interested in